Mavacamten. Allosteric modulator of cardiac myosin, Treatment of hypertrophic cardiomyopathy, Treatment of heart failure with preserved ejection fraction
-
Published:2021
Issue:6
Volume:46
Page:443
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Publisher
Clarivate Analytics (US)
Subject
Pharmacology (medical),Pharmacology